SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
LATEST POSTS
- 1
Figure out how to Separate Among Fledgling and Master Fender bender Legal counselors - 2Artemis II's moon-bound astronauts capture Earth's brilliant blue beauty as they leave it behind
- 3Winter storms blanket the East, while the U.S. West is wondering: Where’s the snow?
- 4British Columbia's Secret Lakeside Town With Hot Springs Is 'An Oasis Of Arts, Culture And Relaxation'
- 5Exclusive-Drugmakers raise US prices on 350 medicines despite pressure from Trump
- Europe: 4 Urban communities for a Paramount Social Experience
- Man threatens attack on German high-speed train, 12 lightly injured
- Innovative Versatility: Examples of overcoming adversity from Entrepreneurs
- Top 10 Smash hit Computer games of the Year
- The Best 10 Innovation Developments of the Year
- Step by step instructions to Guarantee Your Lab Precious stone is Morally Obtained
- A single shot of HPV vaccine may be enough to fight cervical cancer, study finds
- Figure out How to Use the Experience of a Fender bender Legal counselor for Your Potential benefit
- Thousands of Walgreens nasal spray bottles recalled. See which ones.
